Dabur Pharma shoots up on product approval
Dabur Pharma gained 4.78 per cent to Rs 55.65 after the company received approval to sell the irinotecan hydrochloride injection in Italy and Denmark.
Dabur Pharma gained 4.78 per cent to Rs 55.65 after the company received approval to sell the irinotecan hydrochloride injection in Italy and Denmark.